Matches in Wikidata for { <http://www.wikidata.org/entity/Q56980856> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q56980856 description "article scientifique publié en 2018" @default.
- Q56980856 description "article" @default.
- Q56980856 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56980856 description "wetenschappelijk artikel" @default.
- Q56980856 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q56980856 name "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 name "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 type Item @default.
- Q56980856 label "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 label "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 prefLabel "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 prefLabel "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 P1433 Q56980856-83FBABD7-0231-477E-9FCE-E06B36FC44BB @default.
- Q56980856 P1476 Q56980856-B453BA0F-ACF1-4047-8DB9-DB84EA10C8F6 @default.
- Q56980856 P2093 Q56980856-08355F55-084D-48BE-8718-BB3B97C14B8F @default.
- Q56980856 P2093 Q56980856-B15CBA79-25A3-4071-8D98-3975C3A69D7D @default.
- Q56980856 P2093 Q56980856-D727CE51-1641-4FCF-A89F-F92EF5A0A63B @default.
- Q56980856 P2093 Q56980856-DD6FDE15-CC5F-4832-BAE8-F85CF7123E00 @default.
- Q56980856 P2093 Q56980856-F6DA21F1-E0DD-4A5F-9296-A39436F0B90F @default.
- Q56980856 P304 Q56980856-441986B0-C09F-492E-80E4-8FAA2D2D388A @default.
- Q56980856 P31 Q56980856-773AD93C-0290-4292-8353-7BF60198362C @default.
- Q56980856 P356 Q56980856-9C3E6A07-55F7-4EEE-9E00-6C33FAE1902F @default.
- Q56980856 P407 Q56980856-61916D9F-87A2-44E3-ABB9-84F049D1A46F @default.
- Q56980856 P433 Q56980856-4F2B4366-534E-4A5E-B3A3-B75862C29BFD @default.
- Q56980856 P478 Q56980856-7D5B6DAB-86A4-4DC6-AC23-FDD53B4B1146 @default.
- Q56980856 P577 Q56980856-A382E60F-5EE1-458A-AA95-79867A65EC48 @default.
- Q56980856 P698 Q56980856-332333DA-8F94-483F-ABBD-8F05CB4E3B6A @default.
- Q56980856 P356 J.IJPHARM.2018.08.012 @default.
- Q56980856 P698 30107219 @default.
- Q56980856 P1433 Q6051539 @default.
- Q56980856 P1476 "Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation" @default.
- Q56980856 P2093 "Eun Seok Park" @default.
- Q56980856 P2093 "Hye-Jin Seo" @default.
- Q56980856 P2093 "Prakash Thapa" @default.
- Q56980856 P2093 "Seong Hoon Jeong" @default.
- Q56980856 P2093 "Shin Jung Park" @default.
- Q56980856 P304 "388-396" @default.
- Q56980856 P31 Q13442814 @default.
- Q56980856 P356 "10.1016/J.IJPHARM.2018.08.012" @default.
- Q56980856 P407 Q1860 @default.
- Q56980856 P433 "1-2" @default.
- Q56980856 P478 "549" @default.
- Q56980856 P577 "2018-08-11T00:00:00Z" @default.
- Q56980856 P698 "30107219" @default.